This tip was tested on an iPhone 16 running iOS 26. Your iPhone needs to be updated to iOS 26 to run this feature. Find out how to update to the latest version of iOS ...
VectorY gains exclusive rights to evaluate and potentially license SHP-DB1, enhancing its neurodegenerative disease therapy pipeline. SHP-DB1, an engineered AAV5 capsid, offers improved brain ...
AMSTERDAM & BOSTON & SEATTLE--(BUSINESS WIRE)--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, and ...
VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for Neurodegenerative Diseases Using an AAV5-Derived CNS Capsid ~ Agreement grants ...
~ Agreement grants VectorY the exclusive right to evaluate and license Shape’s non-invasive, deep-brain penetrating AAV5-derived capsid for vectorized antibodies against three targets ~ ~ License will ...
Abstract: In diagnosing and treating prostate cancer the flexible bevel tip needle insertion surgical technique is commonly used. Bevel tip needles experience asymmetric loading on the needle’s tip, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback